| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4014307
[patent_doc_number] => 05880134
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT.sub.7 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/930747
[patent_app_country] => US
[patent_app_date] => 1997-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 4958
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880134.pdf
[firstpage_image] =>[orig_patent_app_number] => 930747
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/930747 | Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT.sub.7 receptor | Oct 6, 1997 | Issued |
Array
(
[id] => 3833880
[patent_doc_number] => 05814656
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Selective prevention of organ injury is sepsis and shock using selective release of nitric oxide vulnerable organs'
[patent_app_type] => 1
[patent_app_number] => 8/942896
[patent_app_country] => US
[patent_app_date] => 1997-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 9434
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814656.pdf
[firstpage_image] =>[orig_patent_app_number] => 942896
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/942896 | Selective prevention of organ injury is sepsis and shock using selective release of nitric oxide vulnerable organs | Oct 1, 1997 | Issued |
| 08/930214 | COMBINATION COMPOSITIONS CONTAINING BENAZEPRIL OR BENAZEPRILAT AND VALSARTAN | Sep 29, 1997 | Abandoned |
Array
(
[id] => 4002976
[patent_doc_number] => 05858998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases'
[patent_app_type] => 1
[patent_app_number] => 8/940211
[patent_app_country] => US
[patent_app_date] => 1997-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3118
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858998.pdf
[firstpage_image] =>[orig_patent_app_number] => 940211
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/940211 | Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases | Sep 29, 1997 | Issued |
Array
(
[id] => 3997836
[patent_doc_number] => 05922736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Chronic, bolus administration of D-threo methylphenidate'
[patent_app_type] => 1
[patent_app_number] => 8/937684
[patent_app_country] => US
[patent_app_date] => 1997-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5273
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922736.pdf
[firstpage_image] =>[orig_patent_app_number] => 937684
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/937684 | Chronic, bolus administration of D-threo methylphenidate | Sep 28, 1997 | Issued |
Array
(
[id] => 6684024
[patent_doc_number] => 20030119888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'COMPOSITION COMPRISING L-ARGININE AS A MUSCLE GROWTH STIMULANT AND USE THEREOF'
[patent_app_type] => new
[patent_app_number] => 08/938801
[patent_app_country] => US
[patent_app_date] => 1997-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3776
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119888.pdf
[firstpage_image] =>[orig_patent_app_number] => 08938801
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/938801 | Composition comprising L-arginine as a muscle growth stimulant and use thereof | Sep 25, 1997 | Issued |
Array
(
[id] => 3983673
[patent_doc_number] => 05958928
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Pharmaceutical agents containing methotrexate derivative'
[patent_app_type] => 1
[patent_app_number] => 8/913967
[patent_app_country] => US
[patent_app_date] => 1997-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1931
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958928.pdf
[firstpage_image] =>[orig_patent_app_number] => 913967
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/913967 | Pharmaceutical agents containing methotrexate derivative | Sep 24, 1997 | Issued |
Array
(
[id] => 3984414
[patent_doc_number] => 05958976
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Composition and method for reducing stinging in skin'
[patent_app_type] => 1
[patent_app_number] => 8/933571
[patent_app_country] => US
[patent_app_date] => 1997-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2259
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958976.pdf
[firstpage_image] =>[orig_patent_app_number] => 933571
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/933571 | Composition and method for reducing stinging in skin | Sep 18, 1997 | Issued |
Array
(
[id] => 3938106
[patent_doc_number] => 05976578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Liquid antacid compositions'
[patent_app_type] => 1
[patent_app_number] => 8/932625
[patent_app_country] => US
[patent_app_date] => 1997-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3358
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976578.pdf
[firstpage_image] =>[orig_patent_app_number] => 932625
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/932625 | Liquid antacid compositions | Sep 16, 1997 | Issued |
Array
(
[id] => 3995358
[patent_doc_number] => 05985830
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Use of IGF-I for the treatment of kidney disorders'
[patent_app_type] => 1
[patent_app_number] => 8/933196
[patent_app_country] => US
[patent_app_date] => 1997-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11322
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985830.pdf
[firstpage_image] =>[orig_patent_app_number] => 933196
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/933196 | Use of IGF-I for the treatment of kidney disorders | Sep 15, 1997 | Issued |
Array
(
[id] => 3985129
[patent_doc_number] => 05891393
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Method for the microbial decontamination of blood platelets'
[patent_app_type] => 1
[patent_app_number] => 8/945395
[patent_app_country] => US
[patent_app_date] => 1997-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5231
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891393.pdf
[firstpage_image] =>[orig_patent_app_number] => 945395
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945395 | Method for the microbial decontamination of blood platelets | Sep 11, 1997 | Issued |
Array
(
[id] => 4004846
[patent_doc_number] => 06004967
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Psoriasis treatment with quinazoline compounds'
[patent_app_type] => 1
[patent_app_number] => 8/927442
[patent_app_country] => US
[patent_app_date] => 1997-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11261
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004967.pdf
[firstpage_image] =>[orig_patent_app_number] => 927442
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/927442 | Psoriasis treatment with quinazoline compounds | Sep 10, 1997 | Issued |
Array
(
[id] => 3987653
[patent_doc_number] => 05910501
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders'
[patent_app_type] => 1
[patent_app_number] => 8/921956
[patent_app_country] => US
[patent_app_date] => 1997-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4369
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910501.pdf
[firstpage_image] =>[orig_patent_app_number] => 921956
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/921956 | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders | Aug 25, 1997 | Issued |
Array
(
[id] => 4192561
[patent_doc_number] => 06043217
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Amide derivative of amythiamicin'
[patent_app_type] => 1
[patent_app_number] => 8/915118
[patent_app_country] => US
[patent_app_date] => 1997-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7491
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043217.pdf
[firstpage_image] =>[orig_patent_app_number] => 915118
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/915118 | Amide derivative of amythiamicin | Aug 19, 1997 | Issued |
Array
(
[id] => 3967061
[patent_doc_number] => 05886021
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis'
[patent_app_type] => 1
[patent_app_number] => 8/912802
[patent_app_country] => US
[patent_app_date] => 1997-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2117
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/886/05886021.pdf
[firstpage_image] =>[orig_patent_app_number] => 912802
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/912802 | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis | Aug 17, 1997 | Issued |
Array
(
[id] => 3777067
[patent_doc_number] => 05756844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Concentrated aminoanthraquinone blue colorants'
[patent_app_type] => 1
[patent_app_number] => 8/911889
[patent_app_country] => US
[patent_app_date] => 1997-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1830
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756844.pdf
[firstpage_image] =>[orig_patent_app_number] => 911889
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/911889 | Concentrated aminoanthraquinone blue colorants | Aug 14, 1997 | Issued |
| 08/911563 | METHOD OF ENHANCING BIOAVAILABILITY OF FEXOFENADINE AND ITS DERIVATIVES | Aug 13, 1997 | Pending |
Array
(
[id] => 4156925
[patent_doc_number] => 06103755
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Foodstuff with prophylactic and/or healing effect and process for its production'
[patent_app_type] => 1
[patent_app_number] => 8/910751
[patent_app_country] => US
[patent_app_date] => 1997-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3484
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103755.pdf
[firstpage_image] =>[orig_patent_app_number] => 910751
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/910751 | Foodstuff with prophylactic and/or healing effect and process for its production | Aug 12, 1997 | Issued |
Array
(
[id] => 3842896
[patent_doc_number] => 05766596
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Aconite tuber-sulphur composite preparation and a process for the preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 8/911019
[patent_app_country] => US
[patent_app_date] => 1997-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4539
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766596.pdf
[firstpage_image] =>[orig_patent_app_number] => 911019
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/911019 | Aconite tuber-sulphur composite preparation and a process for the preparation thereof | Aug 12, 1997 | Issued |
Array
(
[id] => 4075197
[patent_doc_number] => 05965596
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-12
[patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissue'
[patent_app_type] => 1
[patent_app_number] => 8/909513
[patent_app_country] => US
[patent_app_date] => 1997-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7195
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/965/05965596.pdf
[firstpage_image] =>[orig_patent_app_number] => 909513
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/909513 | Methods and compositions for increasing the anaerobic working capacity in tissue | Aug 11, 1997 | Issued |